Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: Addressing the threat of an influenza pandemic

导出原文传递

翻译打印收藏纠错

作者： Surichan, Somchaiya ^[1] ; Wirachwong, Ponthip ^[2] ; Supachaturas, Wutichai ; Utid, Kanchala ; Theerasurakarn, Sompone ; Langsanam, Pimsuk ; Lakornrach, Pattharachai ; Nitisaporn, Ladda ; Chansikkakorn, Chanpen ; Vangkanonta, Wilak ; Kaweepornpoj, Ruangchai ; Poopipatpol, Kittisak ; Thirapakpoomanunt, Sit ; Srichainak, Somchai ; Artavatkun, Witit ; Chokevivat, Vichai ; Wibulpolprasert, Suwit .

作者单位： Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand ^[1] Ministry of Public Health, Thailand ^[2]

关键词 H1N1 PLAIV vaccine: immunologic-drug immunostimulant-drug vaccine phase II clinical trial dosage egg-based trivalent inactivated influenza vaccine: immunologic-drug WHO production capacity Government Pharmaceutical Organization TFDA

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交